Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Assandri

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Contraception|February 1, 1981
A new non-hormonal pregnancy-terminating agentG Galliani, A Assandri, L Gallico, et al.
Contraception|March 1, 1986
On the mode of action of a new contragestational agent (DL 111-IT)G Galliani, F Luzzani, G Colombo, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteersB Jansen, U Graselli, S Dallinger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2005
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometryO Arnold, B Saletu, P Anderer, et al.
Contraception|August 1, 1982
DL 111, a new non-hormonal antifertility agent: contragestational and kinetic profile in baboonsG Galliani, A Assandri, L J Lerner, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1984
Metabolic pathways of the contragestational agent, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (DL 111-IT), in the ratA Assandri, A Perazzi, P Ferrari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine+ ++ hydrochloride. I. Studies in the ratA Assandri, A Perazzi, E Baldoli, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1987
Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drugA Assandri, G Tarzia, E Bellasio, et al.
European Journal of Clinical Pharmacology|April 25, 2001
Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairmentC Joukhadar, U Herranz, T Pernerstorfer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dogA Assandri, A Perazzi, E Bellasio, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Contraception|February 1, 1981
A new non-hormonal pregnancy-terminating agentG Galliani, A Assandri, L Gallico, et al.
Contraception|March 1, 1986
On the mode of action of a new contragestational agent (DL 111-IT)G Galliani, F Luzzani, G Colombo, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteersB Jansen, U Graselli, S Dallinger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2005
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometryO Arnold, B Saletu, P Anderer, et al.
Contraception|August 1, 1982
DL 111, a new non-hormonal antifertility agent: contragestational and kinetic profile in baboonsG Galliani, A Assandri, L J Lerner, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 1, 1984
Metabolic pathways of the contragestational agent, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (DL 111-IT), in the ratA Assandri, A Perazzi, P Ferrari, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine+ ++ hydrochloride. I. Studies in the ratA Assandri, A Perazzi, E Baldoli, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1987
Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drugA Assandri, G Tarzia, E Bellasio, et al.
European Journal of Clinical Pharmacology|April 25, 2001
Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairmentC Joukhadar, U Herranz, T Pernerstorfer, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1985
Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dogA Assandri, A Perazzi, E Bellasio, et al.
Pageof 6